Nemonapride

Nemonapride
Clinical data
Trade names Emilace (JP)
AHFS/Drugs.com International Drug Names
Routes of
administration
Oral
ATC code none
Legal status
Legal status
  • Rx-only (JP)
Identifiers
CAS Number 75272-39-8
PubChem (CID) 4452
IUPHAR/BPS 983
ChemSpider 4297
UNII Q88T5P3444 YesY
KEGG D01468 YesY
ChEBI CHEBI:64217
ChEMBL CHEMBL20734
ECHA InfoCard 100.215.765
Chemical and physical data
Formula C21H26ClN3O2
Molar mass 387.90 g/mol
3D model (Jmol) Interactive image
  (verify)

Nemonapride (エミレース, Emilace (JP)) is an atypical antipsychotic approved in Japan for the treatment of schizophrenia. It was launched by Yamanouchi in 1991. Nemonapride acts as a D2 and D3 receptor antagonist, and is also a potent 5-HT1A receptor agonist. It has affinity for sigma receptors.

See also

References


    This article is issued from Wikipedia - version of the 5/27/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.